Solomon Iyasu, MD FDA

Solomon Iyasu, MD, MPH is the Director of the Office of Phamacovigilance and Epidemiology, Office of Surveillance and Evaluation, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) with expertise in medical epidemiology, postmarket medical product safety assessment and regulation of medical products. Dr. Iyasu has been with FDA since 2002 and has worked in pediatric drug development and safety evaluation, post market passive and active medical product safety surveillance systems, development and application of pharmacopidemiology safety studies and building regulatory drug safety research programs. Prior to FDA, he worked at the Centers for Disease Control and Prevention conducting perinatal and pediatric epidemiology studies to evaluate pregnancy and infant outcomes. Dr. Iyasu has published several scientific research papers and book chapters pertaining to medical product safety, regulatory policy and public health. Dr. Iyasu is trained in medicine, epidemiology and completed a residency in Preventive Medicine.